733.2K XNAS Volume
XNAS 25 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Clare Kahn | Director | Purchase of securities on an exchange or from another person at price $ 5.34 per share. | 11 Mar 2025 | 1,860 | 2,960 (0%) | 0% | 5.3 | 9,924 | Common Stock |
| David Tyronne Howton | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 14,687 | 30,350 (0%) | 0% | - | Common Stock | |
| David Tyronne Howton | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 3.96 per share. | 13 Feb 2025 | 5,561 | 24,789 (0%) | 0% | 4.0 | 22,022 | Common Stock |
| David Tyronne Howton | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 14,687 | 44,063 | - | - | Restricted Stock Units | |
| Alexander G. Cumbo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.96 per share. | 13 Feb 2025 | 11,365 | 60,717 (0%) | 0% | 4.0 | 45,005 | Common Stock |
| Alexander G. Cumbo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 30,031 | 90,094 | - | - | Restricted Stock Units | |
| Alexander G. Cumbo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 30,031 | 72,082 (0%) | 0% | - | Common Stock | |
| Ilan Ganot | Director | Sale of securities on an exchange or to another person at price $ 3.96 per share. | 13 Feb 2025 | 1,711 | 14,839 (0%) | 0% | 4.0 | 6,776 | Common Stock |
| Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,861 | 16,550 (0%) | 0% | - | Common Stock | |
| Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,861 | 14,583 | - | - | Restricted Stock Units | |
| Kevin Tan | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 10,625 | 35,414 (0%) | 0% | - | Common Stock | |
| Kevin Tan | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 10,625 | 31,875 | - | - | Restricted Stock Units | |
| Kevin Tan | CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 3.96 per share. | 13 Feb 2025 | 3,164 | 32,250 (0%) | 0% | 4.0 | 12,529 | Common Stock |
| Paul Herzich | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 3.96 per share. | 13 Feb 2025 | 2,688 | 18,388 (0%) | 0% | 4.0 | 10,644 | Common Stock |
| Paul Herzich | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 7,187 | 21,076 (0%) | 0% | - | Common Stock | |
| Paul Herzich | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 7,187 | 21,563 | - | - | Restricted Stock Units | |
| Jessie Hanrahan | Chief Regulatory Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 8,125 | 22,360 (0%) | 0% | - | Common Stock | |
| Jessie Hanrahan | Chief Regulatory Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 8,125 | 24,375 | - | - | Restricted Stock Units | |
| Jessie Hanrahan | Chief Regulatory Officer | Sale of securities on an exchange or to another person at price $ 3.96 per share. | 13 Feb 2025 | 3,079 | 19,281 (0%) | 0% | 4.0 | 12,193 | Common Stock |
| Gabriel Brooks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 10,937 | 32,813 | - | - | Restricted Stock Units | |
| Gabriel Brooks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 10,937 | 26,068 (0%) | 0% | - | Common Stock | |
| Gabriel Brooks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.96 per share. | 13 Feb 2025 | 3,256 | 22,812 (0%) | 0% | 4.0 | 12,894 | Common Stock |
| David Tyronne Howton | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 169,100 | 169,100 | - | - | Restricted Stock Units | |
| Alexander G. Cumbo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 401,600 | 401,600 | - | - | Restricted Stock Units | |
| Ilan Ganot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 60,000 | 60,000 | - | - | Restricted Stock Units | |
| Kevin Tan | CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 132,300 | 132,300 | - | - | Restricted Stock Units | |
| Paul Herzich | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 98,700 | 98,700 | - | - | Restricted Stock Units | |
| Jessie Hanrahan | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 110,500 | 110,500 | - | - | Restricted Stock Units | |
| Gabriel Brooks | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 112,900 | 112,900 | - | - | Restricted Stock Units | |
| Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 388 | 11,833 (0%) | 0% | - | Common Stock | |
| Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 3,883 | 3,884 | - | - | Restricted Stock Units | |
| Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 388 | 389 | - | - | Restricted Stock Units | |
| Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 3,883 | 98,690 (0%) | 0% | - | Common Stock | |
| Ilan Ganot | Director | Sale of securities on an exchange or to another person at price $ 3.11 per share. | 27 Jan 2025 | 144 | 11,689 (0%) | 0% | 3.1 | 448 | Common Stock |
| Kevin Tan | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2025 | 11,250 | 28,862 (0%) | 0% | - | Common Stock | |
| Kevin Tan | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2025 | 11,250 | 22,500 | - | - | Restricted Stock Units | |
| Kevin Tan | CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 3.89 per share. | 09 Jan 2025 | 4,073 | 24,789 (0%) | 0% | 3.9 | 15,849 | Common Stock |
| Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 3,255 | 112,972 (0%) | 0% | - | Common Stock | |
| Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 3,255 | 0 | - | - | Restricted Stock Units | |
| Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 22,148 | 22,148 | - | - | Stock Option (Right to Buy) | |
| Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 18,293 | 18,293 | - | - | Restricted Stock Units | |
| Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 2,994 | 12,501 (0%) | 0% | - | Common Stock | |
| Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 2,994 | 5,988 | - | - | Restricted Stock Units | |
| Ilan Ganot | Director | Sale of securities on an exchange or to another person at price $ 4.31 per share. | 03 Jan 2025 | 1,056 | 11,445 (0%) | 0% | 4.3 | 4,551 | Common Stock |
| Tyronne David Howton | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 13,051 | 26,103 | - | - | Restricted Stock Units | |
| Jessie Hanrahan | Chief Regulatory Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 11,862 | 23,725 | - | - | Restricted Stock Units | |
| Tyronne Howton David | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 5.60 per share. | 02 Dec 2024 | 5,072 | 15,663 (0%) | 0% | 5.6 | 28,396 | Common Stock |
| Paul Herzich | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 7,239 | 14,959 (0%) | 0% | - | Common Stock | |
| Jessie Hanrahan | Chief Regulatory Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 11,862 | 18,845 (0%) | 0% | - | Common Stock | |
| G. Alexander Cumbo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 28,612 | 57,225 | - | - | Restricted Stock Units | |
| Herzich Paul | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 5.60 per share. | 02 Dec 2024 | 2,777 | 12,182 (0%) | 0% | 5.6 | 15,551 | Common Stock |
| Howton David Tyronne | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 13,051 | 20,735 (0%) | 0% | - | Common Stock | |
| G. Cumbo Alexander | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.60 per share. | 02 Dec 2024 | 11,114 | 38,484 (0%) | 0% | 5.6 | 62,236 | Common Stock |
| Herzich Paul | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 7,239 | 14,478 | - | - | Restricted Stock Units | |
| Hanrahan Jessie | Chief Regulatory Officer | Sale of securities on an exchange or to another person at price $ 5.60 per share. | 02 Dec 2024 | 4,610 | 14,235 (0%) | 0% | 5.6 | 25,822 | Common Stock |
| G. Alexander Cumbo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 28,612 | 49,598 (0%) | 0% | - | Common Stock | |
| Gabriel Brooks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Oct 2024 | 9,750 | 29,250 | - | - | Restricted Stock Units | |
| Gabriel Brooks | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.50 per share. | 18 Oct 2024 | 2,923 | 10,979 (0%) | 0% | 6.5 | 19,000 | Common Stock |
| Gabriel Brooks | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Oct 2024 | 9,750 | 13,902 (0%) | 0% | - | Common Stock | |
| Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2024 | 3,255 | 3,255 | - | - | Restricted Stock Units | |
| Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2024 | 3,255 | 109,717 (0%) | 0% | - | Common Stock | |
| Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2024 | 3,255 | 106,462 (0%) | 0% | - | Common Stock | |
| Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2024 | 3,255 | 6,510 | - | - | Restricted Stock Units | |
| Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 34,400 | 34,400 | - | - | Director Stock Option (Right to Buy) | |
| Sukumar Nagendran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 34,400 | 34,400 | - | - | Director Stock Option (Right to Buy) | |
| Martin Freed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 34,400 | 34,400 | - | - | Director Stock Option (Right to Buy) | |
| Ilan Ganot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 34,400 | 34,400 | - | - | Director Stock Option (Right to Buy) | |
| Lynne Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 34,400 | 34,400 | - | - | Director Stock Option (Right to Buy) | |
| Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 34,400 | 34,400 | - | - | Director Stock Option (Right to Buy) | |
| Clare Kahn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 34,400 | 34,400 | - | - | Director Stock Option (Right to Buy) | |
| Adam Stone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 34,400 | 34,400 | - | - | Director Stock Option (Right to Buy) | |
| Clare Kahn | Director | Purchase of securities on an exchange or from another person at price $ 7.67 per share. | 07 Jun 2024 | 1,100 | 1,100 (0%) | 0% | 7.7 | 8,442 | Common Stock |
| Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2024 | 1,553 | 0 | - | - | Restricted Stock Units | |
| Ilan Ganot | Director | Sale of securities on an exchange or to another person at price $ 10.33 per share. | 02 May 2024 | 462 | 9,507 (0%) | 0% | 10.3 | 4,772 | Common Stock |
| Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2024 | 1,553 | 9,969 (0%) | 0% | - | Common Stock | |
| Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2024 | 3,256 | 103,207 (0%) | 0% | - | Common Stock | |
| Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2024 | 3,256 | 9,765 | - | - | Restricted Stock Units | |
| Herzich Paul | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 28,750 | 28,750 | - | - | Restricted Stock Units | |
| Ilan Ganot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 19,444 | 19,444 | - | - | Restricted Stock Units | |
| Hanrahan Jessie | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 65,000 | 65,000 | - | - | Employee Stock Option (Right to Buy) | |
| Gabriel Brooks | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 43,750 | 43,750 | - | - | Restricted Stock Units | |
| Marlowe Jennifer | CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 45,000 | 45,000 | - | - | Restricted Stock Units | |
| Kevin Tan | CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 42,500 | 42,500 | - | - | Restricted Stock Units | |
| Gabriel Brooks | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 87,500 | 87,500 | - | - | Employee Stock Option (Right to Buy) | |
| Howton Tyronne David | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 58,750 | 58,750 | - | - | Restricted Stock Units | |
| Alexander G. Cumbo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 120,125 | 120,125 | - | - | Restricted Stock Units | |
| Hanrahan Jessie | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 32,500 | 32,500 | - | - | Restricted Stock Units | |
| Herzich Paul | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 57,500 | 57,500 | - | - | Employee Stock Option (Right to Buy) | |
| Kevin Tan | CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 85,000 | 85,000 | - | - | Employee Stock Option (Right to Buy) | |
| David Tyronne Howton | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 117,500 | 117,500 | - | - | Employee Stock Option (Right to Buy) | |
| Marlowe Jennifer | CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 90,000 | 90,000 | - | - | Employee Stock Option (Right to Buy) | |
| G. Alexander Cumbo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 240,250 | 240,250 | - | - | Employee Stock Option (Right to Buy) | |
| Ganot Ilan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2024 | 388 | 777 | - | - | Restricted Stock Units | |
| Ganot Ilan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2024 | 3,883 | 7,767 | - | - | Restricted Stock Units | |
| Ganot Ilan | Director | Sale of securities on an exchange or to another person at price $ 7.99 per share. | 27 Jan 2024 | 139 | 8,416 (0%) | 0% | 8.0 | 1,111 | Common Stock |
| Ganot Ilan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2024 | 388 | 8,555 (0%) | 0% | - | Common Stock | |
| Ganot Ilan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2024 | 3,883 | 94,807 (0%) | 0% | - | Common Stock | |
| Koppel M. Adam | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 5.53 per share. | 11 Jan 2024 | 904,160 | 4,034,582 (8%) | 1% | 5.5 | 5,000,005 | Common Stock |
| Tan Kevin | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 11,250 | 33,750 | - | - | Restricted Stock Units | |
| Kevin Tan | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 11,250 | 13,243 (0%) | 0% | - | Common Stock | |
| Kevin Tan | CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 8.20 per share. | 09 Jan 2024 | 3,935 | 9,308 (0%) | 0% | 8.2 | 32,267 | Common Stock |
| Ganot Ilan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 2,993 | 8,982 | - | - | Restricted Stock Units | |
| Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 2,993 | 9,309 (0%) | 0% | - | Common Stock | |
| F. Smith Ian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 15,112 | 15,112 | - | - | Stock Option (Right to Buy) | |
| Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 15,570 | 0 | - | - | Restricted Stock Units | |
| F. Ian Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 13,021 | 13,021 | - | - | Restricted Stock Units | |
| Ilan Ganot | Director | Sale of securities on an exchange or to another person at price $ 5.30 per share. | 03 Jan 2024 | 1,142 | 8,167 (0%) | 0% | 5.3 | 6,052 | Common Stock |
| Smith F. Ian | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 15,570 | 99,948 (0%) | 0% | - | Common Stock | |
| Cumbo Alexander G. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 28,612 | 85,837 | - | - | Restricted Stock Units | |
| Ganot Ilan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 1,583 | 0 | - | - | Restricted Stock Units | |
| Herzich Paul | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 7,238 | 21,717 | - | - | Restricted Stock Units | |
| Howton David Tyronne | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 13,051 | 39,154 | - | - | Restricted Stock Units | |
| Jennifer Marlowe | CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 11,888 | 35,667 | - | - | Restricted Stock Units | |
| Howton David Tyronne | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 2.78 per share. | 02 Dec 2023 | 5,367 | 7,684 (0%) | 0% | 2.8 | 14,920 | Common Stock |
| Ganot Ilan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 1,583 | 90,924 (0%) | 0% | - | Common Stock | |
| Cumbo G. Alexander | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.77 per share. | 02 Dec 2023 | 11,757 | 17,439 (0%) | 0% | 2.8 | 32,516 | Common Stock |
| Herzich Paul | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 2.77 per share. | 02 Dec 2023 | 2,968 | 4,270 (0%) | 0% | 2.8 | 8,232 | Common Stock |
| Jessie Hanrahan | Chief Regulatory Officer | Sale of securities on an exchange or to another person at price $ 2.78 per share. | 02 Dec 2023 | 4,879 | 6,983 (0%) | 0% | 2.8 | 13,562 | Common Stock |
| Jessie Hanrahan | Chief Regulatory Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 11,862 | 35,587 | - | - | Restricted Stock Units | |
| Howton Tyronne David | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 13,051 | 13,051 (0%) | 0% | - | Common Stock | |
| Marlowe Jennifer | CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 11,888 | 11,888 (0%) | 0% | - | Common Stock | |
| Alexander Cumbo G. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 28,612 | 29,196 (0%) | 0% | - | Common Stock | |
| Paul Herzich | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 7,238 | 7,238 (0%) | 0% | - | Common Stock | |
| Jennifer Marlowe | CSO | Sale of securities on an exchange or to another person at price $ 2.77 per share. | 02 Dec 2023 | 4,890 | 6,998 (0%) | 0% | 2.8 | 13,525 | Common Stock |
| Jessie Hanrahan | Chief Regulatory Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 11,862 | 11,862 (0%) | 0% | - | Common Stock | |
| Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2023 | 15,570 | 31,139 | - | - | Restricted Stock Units | |
| Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2023 | 15,570 | 68,809 (0%) | 0% | - | Common Stock | |
| Adam M. Koppel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Sukumar Nagendran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Martin Freed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Adam Stone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Lynne Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Clare Kahn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2023 | 1,583 | 87,758 (0%) | 0% | - | Common Stock | |
| Ilan Ganot | Director | Sale of securities on an exchange or to another person at price $ 4.85 per share. | 02 May 2023 | 487 | 4,153 (0%) | 0% | 4.9 | 2,364 | Common Stock |
| Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2023 | 1,553 | 4,640 (0%) | 0% | - | Common Stock | |
| Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2023 | 1,583 | 3,166 | - | - | Restricted Stock Units | |
| Ilan Ganot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2023 | 1,553 | 1,553 | - | - | Restricted Stock Units | |
| Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2023 | 15,569 | 53,239 (0%) | 0% | - | Common Stock | |
| Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2023 | 15,569 | 46,709 | - | - | Restricted Stock Units | |
| Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 1,584 | 86,175 (0%) | 0% | - | Common Stock | |
| Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 1,584 | 4,749 | - | - | Restricted Stock Units | |
| Ilan Ganot | Director | Sale of securities on an exchange or to another person at price $ 7.49 per share. | 27 Jan 2023 | 141 | 1,378 (0%) | 0% | 7.5 | 1,056 | Common Stock |
| Ilan Ganot | Director | Sale of securities on an exchange or to another person at price $ 7.49 per share. | 27 Jan 2023 | 1,382 | 84,591 (0%) | 0% | 7.5 | 10,351 | Common Stock |
| Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 3,883 | 85,973 (0%) | 0% | - | Common Stock | |
| Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 388 | 1,519 (0%) | 0% | - | Common Stock | |
| Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 3,883 | 11,650 | - | - | Restricted Stock Units | |
| Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 388 | 1,165 | - | - | Restricted Stock Units | |
| Carl Morris | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 1,233 | 3,700 | - | - | Restricted Stock Units | |
| Carl Morris | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.49 per share. | 27 Jan 2023 | 441 | 19,760 (0%) | 0% | 7.5 | 3,303 | Common Stock |
| Carl Morris | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 1,233 | 20,201 (0%) | 0% | - | Common Stock | |
| Kevin Tan | CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2023 | 45,000 | 45,000 | - | - | Restricted Stock Units | |
| Kevin Tan | CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2023 | 90,000 | 90,000 | - | - | Employee Stock Option (Right to Buy) | |
| Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 1,620 | 0 | - | - | Restricted Stock Units | |
| Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 62,278 | 62,278 | - | - | Restricted Stock Units | |
| Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 70,796 | 70,796 | - | - | Stock Option (Right to Buy) | |
| Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 1,620 | 37,670 (0%) | 0% | - | Common Stock | |
| Ilan Ganot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 11,975 | 11,975 | - | - | Restricted Stock Units | |
| Ilan Ganot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 23,950 | 23,950 | - | - | Employee Stock Option (Right to Buy) | |
| Carl Morris | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 95,110 | 95,110 | - | - | Employee Stock Option (Right to Buy) | |
| Carl Morris | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 47,555 | 47,555 | - | - | Restricted Stock Units | |
| Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Adam M. Koppel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Sukumar Nagendran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Martin Freed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Robert Huffines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Adam Stone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 9,650 | 9,650 | - | - | Stock Option (Right to Buy) | |
| Lynne Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Clare Kahn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 13,172 | 356,380 (0%) | 0% | - | Common Stock | |
| Adam M. Koppel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 2,666 | 2,666 | - | - | Director Stock Option (Right to Buy) | |
| Alexander G. Cumbo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 114,449 | 114,449 | - | - | Restricted Stock Units | |
| Alexander G. Cumbo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 228,900 | 228,900 | - | - | Stock Option (Right to Buy) | |
| Alexander G. Cumbo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 584 | 584 (0%) | 0% | - | Common Stock | |
| Ilan Ganot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 13,333 | 13,333 | - | - | Stock Option (Right to Buy) | |
| Ilan Ganot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 6,333 | 6,333 | - | - | Restricted Stock Units | |
| Paul Herzich | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 28,955 | 28,955 | - | - | Restricted Stock Units | |
| Paul Herzich | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 57,900 | 57,900 | - | - | Stock Option (Right to Buy) | |
| Jennifer Marlowe | CSO, FA & Cardiac | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 47,555 | 47,555 | - | - | Restricted Stock Units | |
| Jennifer Marlowe | CSO, FA & Cardiac | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 95,110 | 95,110 | - | - | Stock Option (Right to Buy) | |
| Jessie Hanrahan | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 47,449 | 47,449 | - | - | Restricted Stock Units | |
| Jessie Hanrahan | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 94,899 | 94,899 | - | - | Stock Option (Right to Buy) | |
| Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 24,312 | 24,312 | - | - | Restricted Stock Units | |
| Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 24,312 | 343,208 (0%) | 0% | - | Common Stock | |
| Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2022 | 24,313 | 318,896 (0%) | 0% | - | Common Stock | |
| Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2022 | 24,313 | 48,624 | - | - | Restricted Stock Units | |
| Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 51,000 | 51,000 | - | - | Director Stock Option (Right to Buy) | |
| Sukumar Nagendran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 51,000 | 51,000 | - | - | Director Stock Option (Right to Buy) | |
| Martin Freed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 51,000 | 51,000 | - | - | Director Stock Option (Right to Buy) | |
| Robert Huffines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 51,000 | 51,000 | - | - | Director Stock Option (Right to Buy) | |
| Adam Stone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 51,000 | 51,000 | - | - | Stock Option (Right to Buy) | |
| Lynne Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 51,000 | 51,000 | - | - | Director Stock Option (Right to Buy) | |
| Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 51,000 | 51,000 | - | - | Director Stock Option (Right to Buy) | |
| Clare Kahn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Clare Kahn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 51,000 | 51,000 | - | - | Director Stock Option (Right to Buy) | |
| Ilan Ganot | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 46,600 | 46,600 | - | - | Restricted Stock Units | |
| Carl Morris | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 296,000 | 296,000 | - | - | Employee Stock Option (Right to Buy) | |
| Erin Powers Brennan | Chief Legal Officer, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 254,000 | 254,000 | - | - | Employee Stock Option (Right to Buy) | |
| Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2022 | 24,313 | 72,937 | - | - | Restricted Stock Units | |
| Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2022 | 24,313 | 294,583 (0%) | 0% | - | Common Stock | |
| Carl Morris | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 1.10 per share. | 14 Mar 2022 | 11,396 | 255,209 (0%) | 0% | 1.1 | 12,536 | Common Stock |
| Carl Morris | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 1.10 per share. | 14 Mar 2022 | 11,269 | 266,605 (0%) | 0% | 1.1 | 12,396 | Common Stock |
| Joel Schneider | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 1.10 per share. | 14 Mar 2022 | 15,272 | 236,270 (0%) | 0% | 1.1 | 16,799 | Common Stock |
| Joel Schneider | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 1.10 per share. | 14 Mar 2022 | 15,232 | 251,542 (0%) | 0% | 1.1 | 16,755 | Common Stock |
| Ilan Ganot | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 1.12 per share. | 10 Feb 2022 | 463 | 2,518 (0%) | 0% | 1.1 | 519 | Common Stock |
| Ilan Ganot | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 233,000 | 233,000 | - | - | Restricted Stock Units | |
| Ilan Ganot | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 23,300 | 23,300 | - | - | Restricted Stock Units | |
| Ilan Ganot | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 46,400 | 46,400 | - | - | Employee Stock Option (Right to Buy) | |
| Ilan Ganot | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 466,000 | 466,000 | - | - | Employee Stock Option (Right to Buy) | |
| Carl Morris | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 74,000 | 74,000 | - | - | Restricted Stock Units | |
| Carl Morris | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 148,000 | 148,000 | - | - | Employee Stock Option (Right to Buy) | |
| Joel Schneider | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 90,000 | 90,000 | - | - | Restricted Stock Units | |
| Joel Schneider | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 180,000 | 180,000 | - | - | Employee Stock Option (Right to Buy) | |
| Erin Powers Brennan | Chief Legal Officer, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 81,250 | 81,250 | - | - | Restricted Stock Units | |
| Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 97,250 | 97,250 | - | - | Restricted Stock Units | |
| Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 194,500 | 194,500 | - | - | Director Stock Option (Right to Buy) | |
| Rajeev Shah | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 30,000 | 30,000 | - | - | Director Stock Option (Right to Buy) | |
| Martin Freed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Adam M. Koppel | Director | Grant, award, or other acquisition of securities at price $ 5.75 per share. | 23 Mar 2021 | 869,565 | 7,929,918 (17%) | 1% | 5.8 | 4,999,999 | Common Stock |
| Carl Morris | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.84 per share. | 12 Mar 2021 | 11,699 | 287,301 (0%) | 0% | 8.8 | 103,459 | Common Stock |
| Carl Morris | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.85 per share. | 12 Mar 2021 | 11,699 | 275,602 (0%) | 0% | 8.8 | 103,488 | Common Stock |
| Joel Schneider | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.84 per share. | 12 Mar 2021 | 11,699 | 268,774 (0%) | 0% | 8.8 | 103,452 | Common Stock |
| Joel Schneider | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.84 per share. | 12 Mar 2021 | 11,699 | 280,473 (0%) | 0% | 8.8 | 103,468 | Common Stock |
| Joel Schneider | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 15,000 | 15,000 | - | - | Employee Stock Option (Right to Buy) | |
| Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Clare Kahn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Erin Powers Brennan | Chief Legal Officer, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 325,000 | 325,000 | - | - | Employee Stock Option (Right to Buy) | |
| Ilan Ganot | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 7.66 per share. | 12 Feb 2021 | 457 | 3,026 (0%) | 0% | 7.7 | 3,501 | Common Stock |
| Ilan Ganot | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2021 | 35,500 | 1,210,534 (2%) | 0% | - | Common Stock | |
| Ilan Ganot | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2021 | 35,500 | 0 | - | - | Restricted Stock Units | |
| Ilan Ganot | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 6.14 per share. | 27 Jan 2021 | 10,713 | 1,199,821 (2%) | 0% | 6.1 | 65,776 | Common Stock |
| Carl Morris | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2021 | 11,500 | 302,459 (0%) | 0% | - | Common Stock | |
| Carl Morris | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2021 | 11,500 | 0 | - | - | Restricted Stock Units | |
| Carl Morris | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.14 per share. | 27 Jan 2021 | 3,459 | 299,000 (0%) | 0% | 6.1 | 21,238 | Common Stock |
| Joel Schneider | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 6.14 per share. | 27 Jan 2021 | 3,443 | 292,172 (0%) | 0% | 6.1 | 21,145 | Common Stock |
| Joel Schneider | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2021 | 11,500 | 295,615 (0%) | 0% | - | Common Stock | |
| Joel Schneider | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2021 | 11,500 | 0 | - | - | Restricted Stock Units | |
| Jennifer Ziolkowski | CFO, Treasurer & Asst. Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2021 | 11,500 | 0 | - | - | Restricted Stock Units | |
| Jennifer Ziolkowski | CFO, Treasurer & Asst. Secy | Sale of securities on an exchange or to another person at price $ 6.14 per share. | 27 Jan 2021 | 3,473 | 335,636 (0%) | 0% | 6.1 | 21,327 | Common Stock |
| Jennifer Ziolkowski | CFO, Treasurer & Asst. Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2021 | 11,500 | 339,109 (0%) | 0% | - | Common Stock | |
| Ilan Ganot | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2021 | 438,000 | 438,000 | - | - | Employee Stock Option (Right to Buy) | |
| Ilan Ganot | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2021 | 8,100 | 8,100 | - | - | Employee Stock Option (Right to Buy) | |
| Carl Morris | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2021 | 175,000 | 175,000 | - | - | Employee Stock Option (Right to Buy) | |
| Joel Schneider | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2021 | 175,000 | 175,000 | - | - | Employee Stock Option (Right to Buy) | |
| Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 389,000 | 389,000 | - | - | Stock Option (Right to Buy) | |
| Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 3.70 per share. | 10 Dec 2020 | 270,270 | 270,270 (0%) | 0% | 3.7 | 999,999 | Common Stock |
| Adam M. Koppel | Director | Grant, award, or other acquisition of securities at price $ 3.70 per share. | 10 Dec 2020 | 3,189,189 | 7,060,353 (15%) | 6% | 3.7 | 11,799,999 | Common Stock |
| Rajeev Shah | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 3.70 per share. | 10 Dec 2020 | 4,938,282 | 8,709,882 (18%) | 10% | 3.7 | 18,271,643 | Common Stock |
| Ilan Ganot | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 3.70 per share. | 10 Dec 2020 | 27,027 | 1,175,034 (2%) | 0% | 3.7 | 100,000 | Common Stock |
| Matthew Arnold | Director | Grant, award, or other acquisition of securities at price $ 3.70 per share. | 10 Dec 2020 | 432,432 | 3,933,429 (8%) | 0% | 3.7 | 1,599,998 | Common Stock |
| Ilan Ganot | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2020 | 800 | 3,737 (0%) | 0% | - | Common Stock | |
| Ilan Ganot | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2020 | 800 | 0 | - | - | Restricted Stock Units | |
| Ilan Ganot | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 2.44 per share. | 12 Aug 2020 | 299 | 3,483 (0%) | 0% | 2.4 | 730 | Common Stock |
| Lynette Herscha | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 2.42 per share. | 27 Jul 2020 | 5,141 | 160,859 (0%) | 0% | 2.4 | 12,438 | Common Stock |
| Lynette Herscha | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2020 | 16,000 | 16,000 | - | - | Restricted Stock Units | |
| Lynette Herscha | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2020 | 16,000 | 166,000 (0%) | 0% | - | Common Stock | |
| Ilan Ganot | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 1,350 | 1,350 | - | - | Employee Stock Option (Right to Buy) | |
| Carl Morris | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2020 | 11,500 | 294,550 (0%) | 0% | - | Common Stock | |
| Carl Morris | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2020 | 11,500 | 11,500 | - | - | Restricted Stock Units | |
| Carl Morris | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 2.42 per share. | 27 Jul 2020 | 3,591 | 290,959 (0%) | 0% | 2.4 | 8,689 | Common Stock |
| Joel Schneider | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 2.42 per share. | 27 Jul 2020 | 4,041 | 284,115 (0%) | 0% | 2.4 | 9,776 | Common Stock |
| Joel Schneider | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2020 | 11,500 | 288,156 (0%) | 0% | - | Common Stock | |
| Joel Schneider | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2020 | 11,500 | 11,500 | - | - | Restricted Stock Units | |
| Jennifer Ziolkowski | CFO, Treasurer & Asst. Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2020 | 11,500 | 331,200 (0%) | 0% | - | Common Stock | |
| Jennifer Ziolkowski | CFO, Treasurer & Asst. Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2020 | 11,500 | 11,500 | - | - | Restricted Stock UNits | |
| Jennifer Ziolkowski | CFO, Treasurer & Asst. Secy | Sale of securities on an exchange or to another person at price $ 2.42 per share. | 27 Jul 2020 | 3,591 | 327,609 (0%) | 0% | 2.4 | 8,687 | Common Stock |
| Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 200,000 | 200,000 | - | - | Director Stock Option (Right to Buy) | |
| Adam M. Koppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 10,000 | 10,000 | - | - | Director Stock Option (Right To Buy) | |
| Adam M. Koppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 30,000 | 30,000 | - | - | Director Stock Option (Right To Buy) | |
| Sukumar Nagendran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 30,000 | 30,000 | - | - | Director Stock Option (Right to Buy) | |
| Sukumar Nagendran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 10,000 | 10,000 | - | - | Director Stock Option (Right to Buy) | |
| Martin Freed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 30,000 | 30,000 | - | - | Director Stock Option (Right to Buy) | |
| Martin Freed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 10,000 | 10,000 | - | - | Director Stock Option (Right to Buy) | |
| Rajeev Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 30,000 | 30,000 | - | - | Director Stock Option (Right to But) | |
| Lynette Herscha | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 75,000 | 150,000 (0%) | 0% | 0 | Common Stock | |
| Carl Morris | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 75,000 | 283,050 (0%) | 0% | 0 | Common Stock | |
| Joel Schneider | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 75,000 | 276,656 (0%) | 0% | 0 | Common Stock | |
| Jennifer Ziolkowski | CFO, Treasurer & Asst. Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 75,000 | 319,700 (0%) | 0% | 0 | Common Stock | |
| Matthew Arnold | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 30,000 | 30,000 | - | - | Director Stock Option (Right to Buy) | |
| Robert Huffines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 30,000 | 30,000 | - | - | Director Stock Option (Right to Buy) | |
| Adam Stone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Lynne Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 30,000 | 30,000 | - | - | Director Stock Option (Right to Buy) | |
| Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2020 | 40,000 | 40,000 | - | - | Director Stock Option (Right to Buy) | |
| Lynette Herscha | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2020 | 75,000 | 75,000 (0%) | 0% | 0 | Common Stock | |
| Carl Morris | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2020 | 75,000 | 208,050 (0%) | 0% | 0 | Common Stock | |
| Joel Schneider | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2020 | 75,000 | 201,656 (0%) | 0% | 0 | Common Stock | |
| Jennifer Ziolkowski | CFO, Treasurer & Asst. Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2020 | 75,000 | 244,700 (0%) | 0% | 0 | Common Stock | |
| Ilan Ganot | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2020 | 800 | 3,230 (0%) | 0% | - | Common Stock | |
| Ilan Ganot | Director, CEO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2020 | 800 | 2,430 | - | - | Restricted Stock Unit | |
| Ilan Ganot | Director, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.15 per share. | 12 Feb 2020 | 293 | 2,937 (0%) | 0% | 3.2 | 923 | Common Stock |
| Ilan Ganot | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2020 | 2,430 | 2,430 (0%) | 0% | 0 | Common Stock | |
| Lynette Herscha | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2020 | 32,000 | 32,000 | - | - | Restricted Stock Unit | |
| Lynette Herscha | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2020 | 65,000 | 65,000 | - | - | Employee Stock Option (Right to Buy) | |
| Ilan Ganot | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2020 | 4,320 | 4,320 | - | - | Employee Stock Option (Right to Buy) | |
| Carl Morris | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2020 | 23,000 | 23,000 | - | - | Restricted Stock Unit | |
| Carl Morris | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2020 | 47,000 | 47,000 | - | - | Employee Stock Option (Right to Buy) | |
| Joel Schneider | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2020 | 47,000 | 47,000 | - | - | Employee Stock Option (Right to Buy) | |
| Joel Schneider | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2020 | 23,000 | 23,000 | - | - | Restricted Stock Unit | |
| Jennifer Ziolkowski | CFO, Treasurer & Asst. Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2020 | 47,000 | 47,000 | - | - | Employee Stock Option (Right to Buy) | |
| Jennifer Ziolkowski | CFO, Treasurer & Asst. Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2020 | 23,000 | 23,000 | - | - | Restricted Stock Unit | |
| Andrey Zarur | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2020 | 10,000 | 10,000 | - | - | Director Stock Option (Right to Buy) | |
| Ilan Ganot | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2019 | 1,600 | 1,600 | - | - | Restricted Stock Units | |
| Adam M. Koppel | None | Grant, award, or other acquisition of securities at price $ 4.65 per share. | 30 Jul 2019 | 1,881,720 | 3,871,164 (8%) | 4% | 4.7 | 8,749,998 | Common Stock |
| Sukumar Nagendran | None | Grant, award, or other acquisition of securities at price $ 4.65 per share. | 25 Jul 2019 | 32,258 | 34,258 (0%) | 0% | 4.7 | 150,000 | Common Stock |
| Martin Freed | None | Grant, award, or other acquisition of securities at price $ 4.65 per share. | 25 Jul 2019 | 53,763 | 53,763 (0%) | 0% | 4.7 | 249,998 | Common Stock |
| Rajeev Shah | None | Grant, award, or other acquisition of securities at price $ 4.65 per share. | 25 Jul 2019 | 1,881,720 | 4,571,164 (9%) | 5% | 4.7 | 8,749,998 | Common Stock |
| Ilan Ganot | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 4.65 per share. | 25 Jul 2019 | 21,505 | 1,123,631 (2%) | 0% | 4.6 | 99,998 | Common Stock |
| Carl Morris | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 4.65 per share. | 25 Jul 2019 | 21,505 | 133,050 (0%) | 0% | 4.6 | 99,998 | Common Stock |
| Matthew Arnold | None | Grant, award, or other acquisition of securities at price $ 4.65 per share. | 25 Jul 2019 | 677,419 | 3,500,997 (7%) | 1% | 4.6 | 3,149,998 | Common Stock |
| Matthew Arnold | None | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jun 2019 | 562,715 | 2,823,578 (6%) | 1% | 0 | Common Stock | |
| Adam M. Koppel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 10,000 | 10,000 | - | - | Director of Stock Option Right To Buy | |
| Sukumar Nagendran | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 10,000 | 10,000 | - | - | Director Stock Option (Right to Buy) | |
| Martin Freed | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 10,000 | 10,000 | - | - | Director Stock Option (Right to Buy) | |
| Rajeev Shah | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 10,000 | 10,000 | - | - | Director Stock Option (Right to Buy) | |
| Andrey Zarur | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 10,000 | 10,000 | - | - | Director Stock Option (Right to Buy) | |
| Matthew Arnold | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 10,000 | 10,000 | - | - | Director Stock Option (Right to Buy) | |
| Robert Huffines | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 10,000 | 10,000 | - | - | Director Stock Option (Right to Buy) | |
| Adam Stone | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Lynne Sullivan | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 10,000 | 10,000 | - | - | Director Stock Option (Right to Buy) | |
| Andrey Zarur | None | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 08 May 2019 | 8,000 | 10,189 (0%) | 0% | 10.0 | 80,039 | Common Stock |
| Lynette Herscha | See Remark | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2019 | 50,000 | 50,000 | - | - | Employee Stock Option (Right to Buy) | |
| Ilan Ganot | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2019 | 155,000 | 155,000 | - | - | Employee Stock Option (Right to Buy) | |
| Alvaro Amorrortu | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2019 | 60,000 | 60,000 | - | - | Employee Stock Option (Right to Buy) | |
| Carl Morris | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2019 | 60,000 | 60,000 | - | - | Employee Stock Option (Right to Buy) | |
| Joel Schneider | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2019 | 60,000 | 60,000 | - | - | Employee Stock Option (Right to Buy) | |
| Jorge A. Quiroz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2019 | 60,000 | 60,000 | - | - | Employee Stock Option (Right to Buy) | |
| Jennifer Ziolkowski | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2019 | 60,000 | 60,000 | - | - | Employee Stock Option (Right to Buy) | |
| Matthew Arnold | None | Sale of securities on an exchange or to another person at price $ 32.20 per share. | 14 Jan 2019 | 3,300 | 3,386,293 (7%) | 0% | 32.2 | 106,258 | Common Stock |
| Matthew Arnold | None | Sale of securities on an exchange or to another person at price $ 31.60 per share. | 14 Jan 2019 | 1,700 | 3,389,593 (7%) | 0% | 31.6 | 53,724 | Common Stock |
| Matthew Arnold | None | Sale of securities on an exchange or to another person at price $ 30.08 per share. | 07 Jan 2019 | 5,000 | 3,391,293 (7%) | 0% | 30.1 | 150,407 | Common Stock |
| Alvaro Amorrortu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 30.07 per share. | 04 Jan 2019 | 9,000 | 153,746 (0%) | 0% | 30.1 | 270,619 | Common Stock |
| Andrey Zarur | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2019 | 100,000 | 100,000 | - | - | Director Stock Option (Right to Buy) | |
| Andrey Zarur | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2019 | 10,000 | 10,000 | - | - | Director Stock Option (Right to Buy) | |
| Adam Koppel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2018 | 8,165 | 8,165 | - | - | Director Stock Option (Right to Buy) | |
| Sukumar Nagendran | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2018 | 17,240 | 17,240 | - | - | Director Stock Option (Right to Buy) | |
| Martin Freed | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2018 | 16,331 | 16,331 | - | - | Director Stock Option (Right to Buy) | |
| Rajeev Shah | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2018 | 8,165 | 8,165 | - | - | Director Stock Option (Right to Buy) | |
| Andrey Zarur | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2018 | 10,000 | 10,000 | - | - | Director Stock Option (Right to Buy) | |
| Matthew Arnold | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2018 | 8,165 | 8,165 | - | - | Director Stock Option (Right to Buy) | |
| Robert Huffines | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2018 | 8,165 | 8,165 | - | - | Director Stock Option (Right to Buy) | |
| Adam Stone | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2018 | 8,165 | 8,165 | - | - | Stock Option (Right to Buy) | |
| Lynne Sullivan | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2018 | 8,165 | 8,165 | - | - | Director Stock Option (Right to Buy) | |
| Alvaro Amorrortu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 30.20 per share. | 03 Dec 2018 | 3,007 | 168,739 (0%) | 0% | 30.2 | 90,823 | Common Stock |
| Alvaro Amorrortu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 32.38 per share. | 03 Dec 2018 | 300 | 162,746 (0%) | 0% | 32.4 | 9,715 | Common Stock |
| Alvaro Amorrortu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 31.44 per share. | 03 Dec 2018 | 5,693 | 163,046 (0%) | 0% | 31.4 | 178,996 | Common Stock |
| Jorge A. Quiroz | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 29.94 per share. | 03 Dec 2018 | 1,200 | 267,042 (0%) | 0% | 29.9 | 35,924 | Common Stock |
| Jorge A. Quiroz | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.21 per share. | 03 Dec 2018 | 6,154 | 260,888 (0%) | 0% | 30.2 | 185,900 | Common Stock |
| Jorge A. Quiroz | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.41 per share. | 03 Dec 2018 | 31,426 | 229,462 (0%) | 0% | 31.4 | 987,147 | Common Stock |
| Jorge A. Quiroz | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 32.24 per share. | 03 Dec 2018 | 1,370 | 228,092 (0%) | 0% | 32.2 | 44,174 | Common Stock |
| Jorge A. Quiroz | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 34.90 per share. | 16 Nov 2018 | 100 | 268,242 (0%) | 0% | 34.9 | 3,490 | Common Stock |
| Andrey Zarur | None | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 16 Nov 2018 | 100 | 691,105 (1%) | 0% | 35 | 3,500 | Common Stock |
| Ilan Ganot | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 30.70 per share. | 15 Nov 2018 | 30,900 | 1,121,226 (3%) | 0% | 30.7 | 948,615 | Common Stock |
| Ilan Ganot | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 31.06 per share. | 15 Nov 2018 | 19,100 | 1,102,126 (3%) | 0% | 31.1 | 593,319 | Common Stock |
| Alvaro Amorrortu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 31.08 per share. | 15 Nov 2018 | 4,300 | 171,746 (0%) | 0% | 31.1 | 133,632 | Common Stock |
| Alvaro Amorrortu | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 30.61 per share. | 15 Nov 2018 | 4,700 | 176,046 (0%) | 0% | 30.6 | 143,847 | Common Stock |
| Joel Schneider | See Remarks | Sale of securities on an exchange or to another person at price $ 30.68 per share. | 15 Nov 2018 | 13,448 | 133,198 (0%) | 0% | 30.7 | 412,555 | Common Stock |
| Joel Schneider | See Remarks | Sale of securities on an exchange or to another person at price $ 31.10 per share. | 15 Nov 2018 | 8,542 | 124,656 (0%) | 0% | 31.1 | 265,625 | Common Stock |
| Sukumar Nagendran | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2018 | 2,760 | 2,760 | - | - | Director Stock Option(Right to Buy) | |
| Gilad Hayeem | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Aug 2018 | 35,653 | 1,948,991 (5%) | 0% | 0 | Common Stock | |
| Adam Koppel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2018 | 1,835 | 1,835 | - | - | Director Stock Option (Right to Buy) | |
| Martin Freed | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2018 | 3,669 | 3,669 | - | - | Director Stock Option(Right to Buy) | |
| Rajeev Shah | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2018 | 1,835 | 1,835 | - | - | Director Stock Option(Right to Buy) | |
| Ilan Ganot | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2018 | 193,000 | 193,000 | - | - | Employee StockOption (Right to Buy) | |
| Matthew Arnold | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2018 | 1,835 | 1,835 | - | - | Director Stock Option(Right to Buy) | |
| Robert Huffines | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2018 | 1,835 | 1,835 | - | - | Director Stock Option(Right to Buy) | |
| Adam Stone | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2018 | 1,835 | 1,835 | - | - | Stock Option (Right to Buy) | |
| Lynne Sullivan | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2018 | 1,835 | 1,835 | - | - | Director Stock Option(Right to Buy) | |
| Alvaro Amorrortu | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2018 | 134,657 | 134,657 | - | - | Employee Stock Option (Right to Buy) | |
| Carl Morris | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2018 | 203,858 | 203,858 | - | - | Employee Stock Option (Right to Buy) | |
| Joel Schneider | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2018 | 105,677 | 105,677 | - | - | Employee Stock Option (Right to Buy) | |
| Jorge A. Quiroz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2018 | 47,061 | 47,061 | - | - | Employee Stock Option (Right to Buy) | |
| Jennifer Ziolkowski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2018 | 66,852 | 66,852 | - | - | Employee Stock Option (Right to Buy) | |
| Adam Koppel | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2018 | 1,991,097 | 0 | - | - | LLC Units | |
| Adam Koppel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2018 | 1,223,240 | 1,991,097 | - | - | LLC Units | |
| Adam Koppel | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2018 | 1,689,444 | 1,689,444 (5%) | 5% | 0 | Common Stock | |
| Adam Koppel | None | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 30 Jan 2018 | 300,000 | 1,989,444 (5%) | 0% | 16 | 4,800,000 | Common Stock |
| Rajeev Shah | None | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 30 Jan 2018 | 1,000,000 | 2,689,444 (7%) | 2% | 16 | 16,000,000 | Common Stock |